FDA OKs Over-The-Counter “Morning After” Pill

Law360, New York (August 24, 2006, 12:00 AM EDT) -- Giving the green light to Barr Pharmaceuticals Inc., the U.S. Food and Drug Administration on Thursday said it would allow the drug maker to sell its Plan B emergency contraceptive pill without a prescription to women age 18 and older.

The broadened accessibility comes after months of heated debate and could foreshadow Senate approval of Acting FDA Commissioner Dr. Andrew von Eschenbach’s nomination as the agency’s head, a process that has been stalled due to the Plan B controversy.

Sen. Hillary Clinton (D-NY) and Sen. Patty...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Tummino et al v. von Eschenbach


Case Number

1:05-cv-00366

Court

New York Eastern

Nature of Suit

Other Statutory Actions

Judge

Edward R. Korman

Date Filed

January 21, 2005

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.